AAAAAA

   
Results: 1-17 |
Results: 17
THE INFLUENCE OF PHARMACOTHERAPY ON SELF-DIRECTED AND EXTERNALLY-DIRECTED AGGRESSION IN SCHIZOPHRENIA
Authors: BEASLEY CM SAYLER ME KIESLER GM POTVIN JH SANGER TM TOLLEFSON GD
Citation: Cm. Beasley et al., THE INFLUENCE OF PHARMACOTHERAPY ON SELF-DIRECTED AND EXTERNALLY-DIRECTED AGGRESSION IN SCHIZOPHRENIA, Schizophrenia research, 29(1-2), 1998, pp. 28-28
DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS
Authors: TRAN PV HAMILTON SH KUNTZ AJ POTVIN JH ANDERSEN SW BEASLEY C TOLLEFSON GD
Citation: Pv. Tran et al., DOUBLE-BLIND COMPARISON OF OLANZAPINE VERSUS RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA AND OTHER PSYCHOTIC DISORDERS, Journal of clinical psychopharmacology, 17(5), 1997, pp. 407-418
EXTRAPYRAMIDAL SYMPTOMS AND TOLERABILITY OF OLANZAPINE VERSUS HALOPERIDOL IN THE ACUTE TREATMENT OF SCHIZOPHRENIA
Authors: TRAN PV DELLVA MA TOLLEFSON GD BEASLEY CM POTVIN JH KIESLER GM
Citation: Pv. Tran et al., EXTRAPYRAMIDAL SYMPTOMS AND TOLERABILITY OF OLANZAPINE VERSUS HALOPERIDOL IN THE ACUTE TREATMENT OF SCHIZOPHRENIA, The Journal of clinical psychiatry, 58(5), 1997, pp. 205-211
BLIND, CONTROLLED, LONG-TERM STUDY OF THE COMPARATIVE INCIDENCE OF TREATMENT-EMERGENT TARDIVE-DYSKINESIA WITH OLANZAPINE OR HALOPERIDOL
Authors: TOLLEFSON GD BEASLEY CM TAMURA RN TRAN PV POTVIN JH
Citation: Gd. Tollefson et al., BLIND, CONTROLLED, LONG-TERM STUDY OF THE COMPARATIVE INCIDENCE OF TREATMENT-EMERGENT TARDIVE-DYSKINESIA WITH OLANZAPINE OR HALOPERIDOL, The American journal of psychiatry, 154(9), 1997, pp. 1248-1254
ANALYSIS OF MORTALITY IN PERGOLIDE-TREATED PATIENTS WITH PARKINSONS-DISEASE
Authors: SAYLER ME STREET JS BOSOMWORTH JC POTVIN JH KOTSANOS JG
Citation: Me. Sayler et al., ANALYSIS OF MORTALITY IN PERGOLIDE-TREATED PATIENTS WITH PARKINSONS-DISEASE, Neuroepidemiology, 15(1), 1996, pp. 26-32
LONG-TERM FLUOXETINE TREATMENT OF BULIMIA-NERVOSA
Authors: GOLDSTEIN DJ WILSON MG THOMPSON VL POTVIN JH RAMPEY AH
Citation: Dj. Goldstein et al., LONG-TERM FLUOXETINE TREATMENT OF BULIMIA-NERVOSA, British Journal of Psychiatry, 166, 1995, pp. 660-666
FLUOXETINE - A RANDOMIZED CLINICAL-TRIAL IN THE TREATMENT OF OBESITY
Authors: GOLDSTEIN DJ RAMPEY AH ENAS GG POTVIN JH FLUDZINSKI LLA LEVINE LR
Citation: Dj. Goldstein et al., FLUOXETINE - A RANDOMIZED CLINICAL-TRIAL IN THE TREATMENT OF OBESITY, International journal of obesity, 18(3), 1994, pp. 129-135
ABSENCE OF A RELATIONSHIP BETWEEN ADVERSE EVENTS AND SUICIDALITY DURING PHARMACOTHERAPY FOR DEPRESSION
Authors: TOLLEFSON GD RAMPEY AH BEASLEY CM ENAS GG POTVIN JH
Citation: Gd. Tollefson et al., ABSENCE OF A RELATIONSHIP BETWEEN ADVERSE EVENTS AND SUICIDALITY DURING PHARMACOTHERAPY FOR DEPRESSION, Journal of clinical psychopharmacology, 14(3), 1994, pp. 163-169
FLUOXETINE, PLACEBO, AND TRICYCLIC ANTIDEPRESSANTS IN MAJOR DEPRESSION WITH AND WITHOUT ANXIOUS FEATURES
Authors: TOLLEFSON GD HOLMAN SL SAYLER ME POTVIN JH
Citation: Gd. Tollefson et al., FLUOXETINE, PLACEBO, AND TRICYCLIC ANTIDEPRESSANTS IN MAJOR DEPRESSION WITH AND WITHOUT ANXIOUS FEATURES, The Journal of clinical psychiatry, 55(2), 1994, pp. 50-59
A MULTICENTER INVESTIGATION OF FIXED-DOSE FLUOXETINE IN THE TREATMENTOF OBSESSIVE-COMPULSIVE DISORDER
Authors: TOLLEFSON GD RAMPEY AH POTVIN JH JENIKE MA RUSH AJ DOMINGUEZ RA KORAN LM SHEAR MK GOODMAN W GENDUSO LA
Citation: Gd. Tollefson et al., A MULTICENTER INVESTIGATION OF FIXED-DOSE FLUOXETINE IN THE TREATMENTOF OBSESSIVE-COMPULSIVE DISORDER, Archives of general psychiatry, 51(7), 1994, pp. 559-567
A MULTICENTER INVESTIGATION OF FIXED-DOSE FLUOXETINE IN THE TREATMENTOF OBSESSIVE-COMPULSIVE-DISORDER (VOL 51, PG 559, 1994)
Authors: TOLLEFSON GD RAMPEY AH POTVIN JH JENIKE MA RUSH AJ DOMINGUEZ RA KORAN LM SHEAR MK GOODMAN W GENDUSO LA
Citation: Gd. Tollefson et al., A MULTICENTER INVESTIGATION OF FIXED-DOSE FLUOXETINE IN THE TREATMENTOF OBSESSIVE-COMPULSIVE-DISORDER (VOL 51, PG 559, 1994), Archives of general psychiatry, 51(11), 1994, pp. 864-864
LONG-TERM WEIGHT-LOSS - THE EFFECT OF PHARMACOLOGICAL AGENTS
Authors: GOLDSTEIN DJ POTVIN JH
Citation: Dj. Goldstein et Jh. Potvin, LONG-TERM WEIGHT-LOSS - THE EFFECT OF PHARMACOLOGICAL AGENTS, The American journal of clinical nutrition, 60(5), 1994, pp. 647-657
FLUOXETINE - ACTIVATING AND SEDATING EFFECTS
Authors: BEASLEY CM POTVIN JH
Citation: Cm. Beasley et Jh. Potvin, FLUOXETINE - ACTIVATING AND SEDATING EFFECTS, International clinical psychopharmacology, 8(4), 1993, pp. 271-275
FLUOXETINE NOT ASSOCIATED WITH INCREASED AGGRESSION IN CONTROLLED CLINICAL-TRIALS
Authors: HEILIGENSTEIN JH BEASLEY CM POTVIN JH
Citation: Jh. Heiligenstein et al., FLUOXETINE NOT ASSOCIATED WITH INCREASED AGGRESSION IN CONTROLLED CLINICAL-TRIALS, International clinical psychopharmacology, 8(4), 1993, pp. 277-280
COMORBID ANXIOUS SIGNS AND SYMPTOMS IN MAJOR DEPRESSION - IMPACT ON FUNCTIONAL WORK CAPACITY AND COMPARATIVE TREATMENT OUTCOMES
Authors: TOLLEFSON GD SOUETRE E THOMANDER L POTVIN JH
Citation: Gd. Tollefson et al., COMORBID ANXIOUS SIGNS AND SYMPTOMS IN MAJOR DEPRESSION - IMPACT ON FUNCTIONAL WORK CAPACITY AND COMPARATIVE TREATMENT OUTCOMES, International clinical psychopharmacology, 8(4), 1993, pp. 281-293
FLUOXETINE VERSUS AMITRIPTYLINE IN THE TREATMENT OF MAJOR DEPRESSION - A MULTICENTER TRIAL
Authors: BEASLEY CM SAYLER ME POTVIN JH
Citation: Cm. Beasley et al., FLUOXETINE VERSUS AMITRIPTYLINE IN THE TREATMENT OF MAJOR DEPRESSION - A MULTICENTER TRIAL, International clinical psychopharmacology, 8(3), 1993, pp. 143-149
ANALYSES OF SUICIDALITY IN DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS OFPHARMACOTHERAPY FOR WEIGHT-REDUCTION
Authors: GOLDSTEIN DJ RAMPEY AH POTVIN JH MASICA DN BEASLEY CM
Citation: Dj. Goldstein et al., ANALYSES OF SUICIDALITY IN DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS OFPHARMACOTHERAPY FOR WEIGHT-REDUCTION, The Journal of clinical psychiatry, 54(8), 1993, pp. 309-316
Risultati: 1-17 |